MedTrace Logo

Innovations to Prevent Relapse Among Low-income African American Smokers

NCT03982576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-11-04

No results posted yet for this study

Summary

The purpose of this research is to study a relapse prevention program for adult former smokers in Northeast Ohio. The study will also look at how different people respond to the program. Participants asked to take part in this study because they contacted the team for help remaining tobacco-free or otherwise expressed interest in the program. The study includes completing surveys and receiving text messages to help stay tobacco free.

Conditions

  • Smoking Cessation

Interventions

OTHER

Nicotine replacement therapy (NRT)

4 weeks of Transdermal nicotine patches or nicotine gum

BEHAVIORAL

CS-CBT intervention

4 group sessions of a novel culturally specific, CBT-based intervention over 2 weeks

BEHAVIORAL

Path2Quit

Path2Quit is a newly developed video-text program, which delivers 6 weeks of CS video messages (1-2 times/day) and provides 24/7 access to messages pulled from 3 keywords (HELP1, JONES, SLIP).

BEHAVIORAL

Relapse prevention program

4 group sessions of a standard relapse prevention program, publicly available at smokefree.gov

BEHAVIORAL

SmokefreeTXT

NCI's 6-week fully automated text-based cessation program that is free to U.S. subscribers, and is available on smokefree.gov. Users can text one of 3 keywords (MOOD, CRAVE, or SLIP) to receive a relevant message from the system 24/7

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Monica Webb Hooper, PhD · Case Western Reserve University, Case Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03982576 on ClinicalTrials.gov